Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors.

By Beata Chertok, B. Moffat, A. David, Faquan Yu, C. Bergemann, B. Ross, V. Yang. Biomaterials, 2008

870 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Introduction to metallic nanoparticles (2010, background): “, rapid DNA sequencing) early detection of inflammatory, cancer, diabetes, and atherosclerosis.[11-20] All these biomedical applications require that the nanoparticles have high magnetization values so as to provide high-resolution MR images.”
Design of a carbon nanotube/magnetic nanoparticle-based peroxidase-like nanocomplex and its application for highly efficient catalytic oxidation of phenols (2009, background): “MNPs have proven particularly useful for various applications relying on their superparamagnetic properties [14, 15].”
Assessment of the Evolution of Cancer Treatment Therapies (2011, methodology): “In vivo targeting of those doxorubicin-loaded nanoparticles injected directly via the main hepatic artery to hepatocellular carcinoma in a rat model was followed by MRI examination.”
An overview on enzyme-mimicking nanomaterials for use in electrochemical and optical assays (2017, background): “Iron oxide nanomaterials have also found many applications such as in hyperthermia treatment of cancer [17], targeted drug delivery [18], contrast agents in magnetic resonance imaging [19], magnetic storage media magnetic inks, capture and separation of analysts, biosensing applications etc.”